Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02273752
Title Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University

Her2-receptor negative breast cancer

renal cell carcinoma

pancreatic endocrine carcinoma



Age Groups: adult
Covered Countries USA

No variant requirements are available.